Prof. Dejan Zurovac

Principal Investigator, KEMRI - Wellcome, Kenya

---

Affiliation(s):

KEMRI – Wellcome – Trust, Kenya

Nuffield Department of Medicine, University of Oxford

Dejan is an epidemiologist and lead scientist of Malaria Case Management and Drug Evaluation Group within the Department of Public Health Research of the KEMRI/Wellcome Trust Research Programme in Nairobi, Kenya. Since 1997 he has worked in several African countries as a medical doctor, health programme manager and public health researcher within the field of malaria control and the quality of health service delivery. He is translational scientist working in close collaboration with Ministry of Health’s National Malaria Control Programmes. Dejan is affiliated to the University of Oxford, UK and Boston University, USA and is member of several national and international advisory and technical working groups on malaria case management, surveillance, monitoring and evaluation, and operational research.

Prof. Bob Snow

Professor of Malaria Epidemiology, University of Oxford, UK, & Principal Scientist, KEMRI - Wellcome Trust, Kenya

---

Email : RSnow@kemri-wellcome.org

Bob has worked in Africa for over 32 years. He is Professor of Malaria Epidemiology at the University of Oxford and Principal Scientist in the programme based in Nairobi. His work began with the first clinical trials of insecticide-treated bed nets (ITN) in The Gambia (1984-1988) and he has since developed a large programme of work from Kenya on the phenotype of malaria disease, its relationship to parasite exposure and its wider public health burden. His work has influenced international strategies for pro-poor access to ITN, how sub-regional, evidence-based platforms can effectively change malaria treatment policies and how inequities in international donor assistance for malaria control can be changed with appropriate data on risk and national economic capacities at global scales. He has published over 400 articles on malaria, he is the longest serving Oxford scientist of the KEMRI-Wellcome Trust collaboration in Kenya (since 1989), he established the MARA pan-African collaboration (1996), was the founding Director of the Malaria Atlas Project (MAP) (2005-2010), is a technical advisor to the Kenyan Government, sits on a number of international malaria advisory panels and is the Senior Advisor to the UK-DFID funded INFORM Project. Bob’s work continues to provide the bridge between basic malaria epidemiology and malaria control policy in the region. From 2015, his work extended to provide support to WHO countries in the Eastern Mediterranean Region. Bob was made a Fellow of the Academy of Sciences in 2008 and an honorary Fellow of the Royal College of Physicians in 2015. He is supported by the Wellcome Trust (UK) as a Principal Fellow

Prof. Philip Bejon

Programme Director, KEMRI - Wellcome Trust

---

Email : PBejon@kemri-wellcome.org Phone : +07-5555-565

I first came to Kilifi in 2002 to conduct Phase I and IIb clinical trials of a candidate malaria vaccine based on viral vectors. I returned to the University of Oxford in 2006 to complete specialist clinical training as a clinical lecturer, and then was appointed as a senior fellow in the NIHR Oxford Biomedical Research Centre. These posts allowed me to remain active in malaria research, leading further trials of GSK’s candidate malaria vaccine “RTS,S”, and as a member of the Malaria Vectored Vaccine Consortium funded to test viral vectored malaria vaccines in several sites in Africa including Kilifi. An MRC Clinician-Scientist Fellowship, allowed me to return to be resident full-time in Kilifi in 2013, and I became Executive Director of the KEMRI-Wellcome Trust Research Programme in September 2014.

Prof. Gilbert Kokwaro

---

Prof. Mike English

Principal Investigator, KEMRI - Wellcome, Kenya, & Professor, Nuffield Department of Medicine, Oxford University, UK

---

Affiliations:

KEMRI – Wellcome Trust

Nuffield Department of Medicine, Oxford University

Mike worked in Kilifi from 1992 on malaria, in the early years of the ‘Kilifi’ programme, and returned to the UK in 1996 to complete specialist training as a General Paediatrician in 1998. He returned to Kilifi in 1999 to rejoin the programme and work on neonatal illnesses as part of a Wellcome Trust Career Development Fellowship while also working as a paediatrician in Kilifi District Hospital. In 2004 after some work at more national level on quality of paediatric care he moved to Nairobi where he continues to work with the programme as a Wellcome Trust Senior Research Fellow. He was made Professor of International Child Health in Oxford in 2010. His work has included developing national, evidence-based guidelines for care of severely ill children and newborns, at first in 2005 and then updated in 2010 andArray 2013. To complement these Mike and colleagues developed the ETAT+ course, adapting WHO’s ETAT course and expanding its scope to include evidence-based case management of serious illness in the child and newborn periods. The ETAT+ course is now provided with the help of multiple colleagues and the Kenya Paediatric Association with training conducted across Kenya and for Kenyan medical students. Others have taken the course to Rwanda, Uganda and Somaliland. More information on this course and the approach to developing national guidelines can be found at www.idoc-africa.org. The Health Services Unit he leads has undertaken long-term studies by a multidisciplinary team on initiating and establishing ‘best-practices’ within rural government hospitals. This has resulted in a Kenyan team working with the support of international collaborators on hospital performance measurement, cost-effectiveness, motivation, task-shifting, and barriers to implementation. More recently work has started on governance, leadership, human resources for health and knowledge translation. The group are well known for their work on measuring and testing interventions to improve paediatric and neonatal quality of care. Mike and the group work closely with the Kenyan Ministry of Health and he provides technical advice to WHO on a range of issues related to child and newborn survival.

Dr. Philip Ayieko

Postdoctoral Researcher, KEMRI- Wellcome, Kenya, & Honorary Research Fellow, Oxford University, UK

---

Phillip has undertaken evidence synthesis, economic evaluations and led the analysis of a previous cluster randomised trial. He is currently leading a team of 8 analysts and data managers who support the 14 clinical information network hospitals and generate its 2 monthly reports. He is leading the analysis of a new cluster randomised trial of CIN hospitals to test alternative forms of feedback.